INTRODUCTION
- Screen babies on day 5 of age (date of birth = day 0) for the following conditions:
- sickle cell disease
- phenylketonuria (PKU)
- congenital hypothyroidism (CHT)
- cystic fibrosis
- medium chain acyl co-A dehydrogenase deficiency (MCADD)
- maple syrup urine disease (MSUD)
- isovaleric acidaemia (IVA)
- glutaric aciduria type 1 (GA1)
- homocystinuria (HCU)
- severe combined immunodeficiency (SCID)
Obtain pre-transfusion bloodspot samples as previous blood transfusions can falsify results
TIMING
Co-ordinate with other tests when possible to minimise invasive procedures
If transfused before day 5
- Collect first bloodspot card before transfusion
- fill 1 circle
- mark card ‘pre-transfusion’
- Collect second bloodspot card at aged 5–8 days and ≥72 hr after blood transfusion
- fill 4 circles
- record whether plasma or red cells transfused
- Staple pre-transfusion and second bloodspot card together and send to West Midlands screening centre via courier service after validation check
- If baby has not received a blood transfusion the pre-transfusion bloodspot card can be discarded appropriately
Multiple transfusions between aged 5–8 days
- Collect 4 bloodspots within this window. Complete with as much time-lapse as possible from any transfusion
- If ≤3 clear days between the last transfusion and routine sample, a repeat sample to be taken ≥3 clear days after the last transfusion
No transfusions before day 5
- Collect routine bloodspot card at day 5
- fill 4 circles and send to West Midlands screening centre via courier service after validation check, irrespective of milk feeds or gestational age
Preterm babies ≤31 weeks and 6 days will require repeat sample at 28 days or discharge home, whichever is the sooner for CHT. Collect 2 bloodspots. Mark the sample ‘CHT preterm’ and write the gestational age on the card
CONSENT AND INFORMATION
- Person undertaking procedure must:
- offer parents an informed choice about screening for their baby, to gain consent and prepare them for the blood sampling procedure
- provide national pre-screening leaflet at least 24 hr before procedure
- parents must understand that they are consenting to storage of residual bloodspots, these can be used for:
- checking screening results
- monitoring and improving the screening programme and health research that does not identify babies
- It is mandatory to include baby’s NHS number on the bloodspot card
- If screening declined:
- for all conditions – send completed card to screening laboratory (without blood sample) clearly marked DECLINE – ALL CONDITIONS
- inform GP, health visitor and Child Health Records Department, in writing, of conditions baby not screened for
- template letters available from: https://www.gov.uk/government/publications/declined-newborn-blood-spot-screening-template-letters
Further information
Detailed information regarding the UK Newborn screening programme can be sourced from:
- Newborn bloodspot screening programme handbook: https://www.gov.uk/government/publications/health-professional-handbook-newborn-blood-spot-screening
- Standards for NHS newborn bloodspot screening: https://www.gov.uk/government/publications/standards-for-nhs-newborn-blood-spot-screening
- Newborn bloodspot screening sampling guidelines: https://www.gov.uk/government/publications/newborn-blood-spot-screening-sampling-guidelines
Date updated: 2024-01-17